PROPEL® (Mometasone Furoate Implant) is clinically proven to improve surgical outcomes for chronic sinusitis sufferers.
When placed in the sinus following surgery, PROPEL decreases scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids and their potential side effects.
The spring-like PROPEL implant props open the ethmoid sinus to maintain the surgical opening, delivers an anti-inflammatory medication directly to the sinus lining, and then dissolves, avoiding the need for removal.
Our KCH ENT physicians are the only physicians in Central Ohio offering this breakthrough procedure.
Call the KCH Department of Specialty Care, Otolaryngology (ENT) at 740.397.0700 to see if PROPEL is the right option for you.
Reference: 1 Han JK, Marple BF, Smith TL et al. IFAR.2012; 2:271-279. The PROPEL Sinus Implant is intended for use following ethmoid sinus surgery to maintain patency. For more information consult your physician or visit www.intersectENT.com to view information including indications, contraindications, warnings, precautions and adverse events. Caution: Federal law (USA) restricts this product to sale by or on the order of a physician. PROPEL® is a registered trademark of Intersect ENT, Inc.